A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, ...

More recently, researchers have been exploring whether Ozempic might also protect against Alzheimer’s. In October 2024, a ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

Glucagon-like peptide 1 receptor agonists, which are found in Ozempic-like drugs, can could cause devastating symptoms in ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

Zack D Films is back at it again, but this time, he's included a gross scene at the end of his clip to highlight Ozempic side ...

The study supports prior research that found the same thing.

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Ozempic belongs to a group of drugs called GLP-1 receptor agonists. The drug works by mimicking the GLP-1 hormone found naturally in your body. By activating GLP-1 receptors in your brain ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.